| Literature DB >> 17570841 |
Christian Garzoni1, Patrice Francois, Antoine Huyghe, Sabine Couzinet, Caroline Tapparel, Yvan Charbonnier, Adriana Renzoni, Sacha Lucchini, Daniel P Lew, Pierre Vaudaux, William L Kelley, Jacques Schrenzel.
Abstract
BACKGROUND: Staphylococcus aureus, a leading cause of chronic or acute infections, is traditionally considered an extracellular pathogen despite repeated reports of S. aureus internalization by a variety of non-myeloid cells in vitro. This property potentially contributes to bacterial persistence, protection from antibiotics and evasion of immune defenses. Mechanisms contributing to internalization have been partly elucidated, but bacterial processes triggered intracellularly are largely unknown.Entities:
Mesh:
Year: 2007 PMID: 17570841 PMCID: PMC1924023 DOI: 10.1186/1471-2164-8-171
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Internalization of . A. Dose-response of internalization assay performed by adding increasing number of bacteria to constant number of cells. The internalization assay was performed as described in the experimental section. After 2 h, cells were detached with trypsin lyzed with dilute Triton X-100, and then internalized bacteria were assessed by count of colony forming units (cfu). B. Intracellular survival assay of S. aureus over a two-week interval. Note that at times after 6 hours, viable bacterial counts decreased, though viable bacteria were recovered from monolayers even 2 weeks after internalization. All values are mean ± standard deviation (SD) of at least three independent experiments. C. Viability tests were performed after 24 hours of internalization using bacterial m.o.i. of 100:1, or the presence of anti-CD95 (1 μg/ml) or etoposide (100 μM final concentration) as pro-apoptotic controls.
Figure 2Schematic representation of conditions subjected to microarray analysis and number of differentially expressed genes. A. Similar expression profiles were observed for the comparisons between the reference condition and the control conditions consisting in i) mock infection (bacteria in cell culture medium) or ii) adherent bacteria (in the presence of cytochalasin D 1 μg/ml). On the opposite, an important number of genes were found differentially regulated between reference condition and internalized bacteria after 2 or 6 h of intracellular survival. See material and methods section for details. B. Numbers of genes found differentially regulated are indicated for each condition. The proportion of non-characterized genes annotated as genes with "unknown function" appears dark grey.
Genes differentially expressed involved in virulence
| Common | Organism | 2 h fold change | 6 h Fold change | Protein name | |
| N315 | 0.17 | 0.19 | Clumping factor | ||
| N315 | 3.23 | fibronectin binding proteins | |||
| N315 | 3.83 | fibronectin binding proteins | |||
| MW2 | 3.08 | β-hemolysin | |||
| N315 | 3.05 | δ-hemolysin | |||
| N315 | 3.12 | γ-hemolysin | |||
| N315 | 3.75 | Intercellular adhesion proteins | |||
| N315 | 3.06 | leukotoxin LukE | |||
| N315 | 0.14 | 0.22 | synergohymenotropic toxin precursor | ||
| N315 | 0.20 | 0.29 | Ser-Asp rich proteins | ||
| N315 | 3.41 | enterotoxin type C3 | |||
| MW2 | 3.60 | 4.76 | enterotoxin C precursor protein | ||
| N315 | 4.90 | 3.70 | extracellular enterotoxin type G precursor | ||
| N315 | 3.46 | 3.09 | extracellular enterotoxin L | ||
| N315 | 3.94 | 6.33 | enterotoxin SeO | ||
| N315 | 3.73 | exotoxin 1 | |||
| N315 | 3.52 | 3.45 | exotoxin 13 | ||
| N315 | 3.77 | 3.73 | exotoxin 14 | ||
| MW2 | 4.95 | exotoxin homolog [Genomic island nu Sa alpha2] | |||
| N315 | 5.00 | 4.69 | exotoxin 3 | ||
| N315 | 0.15 | 0.10 | Protein A | ||
| N315 | 0.14 | 0.11 | V8 protease | ||
| N315 | 3.22 | Staphopain | |||
| N315 | 3.80 | 4.10 | Toxic shock syndrome toxin-1 | ||
| N315 | 3.18 | enterotoxin Yent1 |
Figure 3Changes in gene expression 2 h and 6 h after internalization shown by functional categories. Percent changes at 2 h (white) and 6 h (grey) was calculated by dividing the number of significantly changed genes by total genes at the given time point. Genes were assigned functional groups using annotated public database and metabolic pathways databases (COG). Categories are: E: Amino acid transport and metabolism, G: Carbohydrate transport and metabolism, D: Cell cycle control, cell division, chromosome partitioning, M: Cell wall/membrane/envelope biogenesis, H: Coenzyme transport and metabolism, V: Defense mechanisms, C: Energy production and conversion, R: General function prediction only, P: Inorganic ion transport and metabolism, U: Intracellular trafficking, secretion, and vesicular transport I: Lipid transport and metabolism, F: Nucleotide transport and metabolism, O: Posttranslational modification, protein turnover, chaperones, L: Replication, recombination and repair, Q: Secondary metabolites biosynthesis, transport and catabolism, T: Signal transduction mechanisms, K: Transcription, J: Translation, ribosomal structure and biogenesis, and VF for virulence factor.
Figure 4Global pattern of expression. Patterns of gene expression changes are shown for each of nine possible categories. The most abundant categories (B) were analyzed in depth after grouping by gene function. Numbers of genes in these two categories are also shown.
Figure 5Quantitative PCR validation of microarray data. Dynamic of gene expression changes is shown as fold change by real-time PCR (black bars), or by microarray determination (white bars), at 2 h (A) or 6 h (B) post-infection. Data are mean ± SD of triplicate measurements from 2 independent experiments.
List and characteristics of oligonucleotides used in the qPCR control experiments
| A | ||||
| F | CAAAGAGAAAACATGGTTACCATTATTAA | 29 | ||
| R | CTCAAGCACCTCATAAGGATTATCAG | 26 | ||
| P | AAAAGCCTATGGAAATTGCCCTCGCA | 26 | FAM | |
| F | CAAAGAGAAAACATGGTTACCATTATTAA | 29 | ||
| R | CTCAAGCACCTCATAAGGATTATCAG | 26 | ||
| P | AAAAGCCTATGGAAATTGCCCTCGCA | 26 | FAM | |
| F | CACCATAAATACCCTCAAACTGTTAGAG | 28 | ||
| R | TCATCTTCAGTTGAGCGTTCTTTT | 24 | ||
| P | AAAAGCAAGGCTATCTAA | 18 | FAM | |
| F | CGATGGGCTTCGCTACATTT | 20 | ||
| R | ATGTGCTTGTTGGGTGTTTGTC | 22 | ||
| P | TGGCGCATCAAGCAGATGCAGC | 22 | FAM | |
| F | TGTTGCTAATTTAGACAGTGTACCAGCTA | 29 | ||
| R | TCCCAGAATAATGAATGGTTTAAATG | 26 | ||
| P | CATCCAAACTGCTGTACGTAATAATGGCGG | 30 | FAM | |
| F | GGGAAACCAAAGCGTGTTGT | 20 | ||
| R | TGTCCATGATTCTACAGCACCTACA | 25 | ||
| P | ATATCAAGGTGCCACTGACGTCGCTGT | 27 | FAM |
A Taqman probes with a 3'-TAMRA quencher (Eurogentec, Seraing, Belgium).
B Minor groove binder probe with non-fluorescent quencher bound to the 3'end (Applied Biosystems). All experiments used concentrations of 200 nM and 100 nM for primers and probes, respectively. Primers and probe for hla quantification have been published previously [87,88].